Literature DB >> 28511476

Magnetic Resonance Imaging in Mixed Mullerian Tumour: Report of Two Cases.

Pratiksha Yadav1, Vidhi Bakshi2, Rajul Bhargava2.   

Abstract

Malignant Mixed Mullerian Tumours (MMMTs) or carcinosarcomas of uterus are rare aggressive tumours of mesenchymal origin. It is associated with high incidence of lymphatic, pulmonary and peritoneal metastasis. We hereby present two cases of mixed mullerian tumour. Case-1 was a 60-year-old post menopausal woman who had come with complaint of metrorrhagia and a protruding mass in the vagina. Case-2 was of a 54-year-old post-menopausal woman who came with complaints of heavy vaginal bleeding, pelvic pain since two months. For the assessment of these tumours Magnetic Resonance Imaging (MRI) is preferred imaging modality due to excellent tissue contrast to detect the myometrial invasion, local extent and staging. Preoperative differentiation of mullerian tumour with endometrial carcinoma is important as both have different treatment.

Entities:  

Keywords:  Carcinosarcoma; Polypoidal mass; Uterine neoplasm

Year:  2017        PMID: 28511476      PMCID: PMC5427402          DOI: 10.7860/JCDR/2017/25068.9470

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  14 in total

Review 1.  Association of tamoxifen and uterine sarcoma.

Authors:  D Lawrence Wickerham; Bernard Fisher; Norman Wolmark; John Bryant; Joseph Costantino; Leslie Bernstein; Carolyn D Runowicz
Journal:  J Clin Oncol       Date:  2002-06-01       Impact factor: 44.544

2.  Serum CA125 predicts extrauterine disease and survival in uterine carcinosarcoma.

Authors:  Gloria S Huang; Lydia G Chiu; Juliana S Gebb; Marc J Gunter; Paniti Sukumvanich; Gary L Goldberg; Mark H Einstein
Journal:  Gynecol Oncol       Date:  2007-10-23       Impact factor: 5.482

3.  Uterine neoplasms: MR imaging.

Authors:  J L Worthington; D M Balfe; J K Lee; D J Gersell; J P Heiken; D Ling; H S Glazer; A J Jacobs; M S Kao; B L McClennan
Journal:  Radiology       Date:  1986-06       Impact factor: 11.105

4.  MRI appearances of uterine malignant mixed müllerian tumors.

Authors:  Nishat Bharwani; Anwen Newland; Nina Tunariu; Syed Babar; Anju Sahdev; Andrea G Rockall; Rodney H Reznek
Journal:  AJR Am J Roentgenol       Date:  2010-11       Impact factor: 3.959

Review 5.  Uterine carcinosarcoma.

Authors:  Sherif A El-Nashar; Andrea Mariani
Journal:  Clin Obstet Gynecol       Date:  2011-06       Impact factor: 2.190

6.  Evaluation of endometrial carcinoma on magnetic resonance imaging.

Authors:  A G Rockall; R Meroni; S A Sohaib; K Reynolds; F Alexander-Sefre; J H Shepherd; I Jacobs; R H Reznek
Journal:  Int J Gynecol Cancer       Date:  2007 Jan-Feb       Impact factor: 3.437

7.  Carcinosarcoma of the uterus: MR findings.

Authors:  Yumiko O Tanaka; Hajime Tsunoda; Rie Minami; Hiroyuki Yoshikawa; Manabu Minami
Journal:  J Magn Reson Imaging       Date:  2008-08       Impact factor: 4.813

8.  18F-fluorodeoxyglucose positron emission tomography in uterine carcinosarcoma.

Authors:  Kung-Chu Ho; Chyong-Huey Lai; Tzu-I Wu; Koon-Kwan Ng; Tzu-Chen Yen; Gigin Lin; Ting-Chang Chang; Chun-Chieh Wang; Swei Hsueh; Huei-Jean Huang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-10-19       Impact factor: 9.236

9.  Carcinosarcoma of the uterus: a 40-year experience from the state of Missouri.

Authors:  L L Doss; A S Llorens; E M Henriquez
Journal:  Gynecol Oncol       Date:  1984-05       Impact factor: 5.482

10.  Uterine carcinosarcomas (malignant mixed müllerian tumours): a review with special emphasis on the controversies in management.

Authors:  Rani Kanthan; Jenna-Lynn Senger
Journal:  Obstet Gynecol Int       Date:  2011-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.